In a national clinical trial led by Joslin Diabetes Center’s Beetham Eye Institute, ultrawide field scanning technology significantly improved the ability of experts at a remote central location to identify diabetic retinopathy in a patient, and to judge whether the eye disease warranted referring the patient to an ophthalmologist for further care.

See the original post:
UWF scanning technology increases identification of diabetic retinopathy

Scroll to Top